Relief for patients living with HIV/AIDS in Kenya as US, Kenya end ARVs stalemate

KENYA – National Aids Control Council (NACC) CEO Ruth Masha has said the committee convened by the council held a series of meetings with US representatives where all outstanding issues have been resolved. This comes even as ARVs consignment that arrived into the country in January continues to be held at the Mombasa port. “The resolutions include the signing of a framework and implementation letter to facilitate tax and fee waivers, and distribution of age USAID purchased commodities,” Masha said in a statement. Masha appreciated the long-standing partnership with the…

Read More

Emergex’s dengue vaccine candidate receives regulatory approval for its first phase clinical trial

UK – A company tackling major global infectious disease threats through the development of 100% synthetic ‘set point’ vaccines, Emergex Vaccines Holding has received regulatory approval for its phase 1 clinical trials of its Dengue Vaccine, pepGNP-Dengue. With approval from Swiss regulatory agencies, Emergex is set to enroll its first participants for the trial phase. The naNO-DENGUE phase 1 trials will evaluate Emergex’s novel T-Cell priming vaccine, which has been designed to deliver broad and long-lasting immunity by priming the body’s T-Cell response to provide rapid clearance of infected cells…

Read More

COVID-19 tourism impact could top US$4 trillion loss in developing countries

AFRICA – The economic impact from the plunge in tourism since the pandemic emerged last year could top US$4 trillion, a UN report has said. The joint report by the UN’s World Tourism Organization (UNWTO) and Conference on Trade and Development (UNCTAD) found that the lack of widespread vaccination in developing countries was leading to mounting economic losses. “Tourism is a lifeline for millions, and advancing vaccination to protect communities and support tourism’s safe restart is critical to the recovery of jobs and generation of much-needed resources,” UNWTO Secretary-General Zurab…

Read More

Rwanda tightens restriction measures, including school closure, as Uganda approves Covidex

RWANDA – Rwanda has announced a review of COVID-19 restriction measures due to a surge in cases and the emergence of new variants globally. Schools and higher education institutions in the country will be closed. Provisions for students sitting national exams in July 2021 will be communicated by the ministry of education. Movements in some parts of the country has also prohibited between 6 pm-4 am and businesses conditioned to close by 5 pm. Social gatherings including gatherings held in homes and family visits are prohibited. All meetings have The…

Read More

Serengeti Breweries unveils TSH 2.3b fund to help bars fight against communicable diseases in Tanzania

TANZANIA – Serengeti Breweries Limited (SBL), Tanzania’s leading brewing company, has announced a programme worth over TSH. 2.3 billion (US$ 992,000) to support bars and eateries in Dar es Salaam and other major towns to protect their staff and customers against communicable diseases, including Covid-19.  This initiative dubbed “Raise the Bar”, is part of a global Diageo programme to help outlets, and bars recover from COVID-19 and support jobs and communities around the world. Nairobi and Kampala will also benefit. The fund will roll out over the next two years…

Read More

Swift medical partners with Accentcare as it aims to venture into the home-based health market

CANADA – Digital wound care start-up Swift Medical is partnering with one of the largest home health providers, AccentCare, to get its technology into the hands of thousands of care providers in moves to secure a bigger share of the home health market. Post-acute healthcare company AccentCare serves more than 210,000 individuals across 31 states and plan to use Swift Medical’s digital wound management platform to improve care for the highest complexity wound patients in the home. Swift Medical’s technology is able to capture wound care information by waving the…

Read More

Emzor’s ultra-modern pharmaceutical factory receives government acclamation

NIGERIA – The Federal Government has lauded Nigeria’s leading indigenous pharmaceutical company, Emzor Pharmaceutical Industries Limited, for the indispensable role it has been playing in the nation’s pharmaceutical sector, especially with its latest ultra-modern World Health Organization (WHO) compliant factory. The Permanent Secretary, Federal Ministry of Health, Alhaji Abdulaziz Mashi Abdullahi, gave the commendation on Friday when he led top officials of the ministry to Emzor’s ultra-modern WHO-compliant pharmaceutical factory, also known as Emzor Campus. The factory is sited on more than 60 hectares of land, and is the largest…

Read More

Lilly’s tirzepatide tops list ahead of ozempic as treatment candidate for type 2 diabetes

US – In the just concluded phase 3 trials, the American pharmaceutical company, Eli Lilly have provided results that showed its investigational Gastric inhibitory polypeptide (GIP) and Glucagon-like peptide 1 (GLP-1) inhibitor tirzepatide is superior to Novo Nordisk’s ozempic. The SURPASS-2 study compared the efficacy and safety of tirzepatide 5 mg, 10 mg and 15 mg to Ozempic (semaglutide) 1 mg in adults with inadequately controlled type 2 diabetes, as an add-on to metformin, a prescription medication used to treat diabetes. All three doses of Lilly’s drug demonstrated superior HbA1C…

Read More

A study to map out Nigeria’s pharmaceutical supply chain has been launched

NIGERIA – The Lagos Business School Sustainability Centre (LBSSC) and Bloom Public Health, in partnership with some Nigerian regulatory bodies have launched a study to map out the pharmaceutical supply chain in Nigeria. The objectives of the study are to identify the value-adding activities required in the sector, identify the main performance points and map the market size of each value-adding activity so as to attract investors. The Pharmacists’ Council of Nigeria (PCN), National Institute for Pharmaceutical Research and Development (NIPRD) and PharmaAccess Group, who are incorporated in the study,…

Read More

‘Mix match’ COVID-19 vaccine approach under consideration following promising results

UK – The UK based Com-Cov study, involving trial usage of two different COVID-19 vaccines, that began early this year has brought back positive with data showing it is still potent against protecting an individual from the virus. This is the ever first trial in the world to evaluate the effects of using different COVID-19 vaccines for the first and second dose within a two-dose vaccination regimen. It is designed to monitor the impact of the different dosing regimens on immune responses and is being run by the National Immunization…

Read More